Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSynergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.AuthorsBonavida, B; Tsuchitani, T; Zighelboim, J; Berek, JSPublicationInternational Journal of Gynecology & Obstetrics, 1991, Vol 36, Issue 1, p80ISSN0020-7292Publication typeArticleDOI10.1016/0020-7292(91)90194-A